Vanguard Group Inc. Cuts Stock Position in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA)

Vanguard Group Inc. lowered its holdings in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) by 0.4% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 34,852,559 shares of the real estate investment trust’s stock after selling 138,597 shares during the period. Vanguard Group Inc. owned about 14.65% of Sabra Healthcare REIT worth $608,874,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also bought and sold shares of the company. UMB Bank n.a. raised its stake in shares of Sabra Healthcare REIT by 379.6% in the first quarter. UMB Bank n.a. now owns 2,048 shares of the real estate investment trust’s stock valued at $36,000 after buying an additional 1,621 shares during the period. Assetmark Inc. raised its stake in shares of Sabra Healthcare REIT by 37.8% in the first quarter. Assetmark Inc. now owns 3,607 shares of the real estate investment trust’s stock valued at $63,000 after buying an additional 989 shares during the period. Fifth Third Bancorp raised its stake in shares of Sabra Healthcare REIT by 110.3% in the first quarter. Fifth Third Bancorp now owns 3,835 shares of the real estate investment trust’s stock valued at $67,000 after buying an additional 2,011 shares during the period. GF Fund Management CO. LTD. bought a new stake in shares of Sabra Healthcare REIT in the fourth quarter valued at $74,000. Finally, Harbor Capital Advisors Inc. raised its stake in shares of Sabra Healthcare REIT by 17.2% in the first quarter. Harbor Capital Advisors Inc. now owns 4,377 shares of the real estate investment trust’s stock valued at $76,000 after buying an additional 642 shares during the period. Hedge funds and other institutional investors own 99.40% of the company’s stock.

Analyst Ratings Changes

Several analysts have issued reports on SBRA shares. Scotiabank boosted their target price on Sabra Healthcare REIT from $19.00 to $20.00 and gave the company a “sector perform” rating in a research note on Monday, June 23rd. JMP Securities boosted their target price on Sabra Healthcare REIT from $20.00 to $22.00 and gave the company a “market outperform” rating in a research note on Wednesday, August 6th. Three analysts have rated the stock with a hold rating, three have given a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $20.00.

Sabra Healthcare REIT Stock Performance

Shares of SBRA opened at $18.53 on Thursday. The stock’s 50-day simple moving average is $18.31 and its 200 day simple moving average is $17.59. The stock has a market capitalization of $4.44 billion, a price-to-earnings ratio of 24.38, a price-to-earnings-growth ratio of 1.54 and a beta of 0.86. The company has a debt-to-equity ratio of 0.91, a quick ratio of 4.80 and a current ratio of 4.80. Sabra Healthcare REIT, Inc. has a 52-week low of $15.60 and a 52-week high of $20.03.

Sabra Healthcare REIT (NASDAQ:SBRA) last issued its quarterly earnings data on Monday, August 4th. The real estate investment trust reported $0.38 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.36 by $0.02. The business had revenue of $189.15 million for the quarter, compared to analysts’ expectations of $185.64 million. Sabra Healthcare REIT had a return on equity of 6.69% and a net margin of 24.87%. The firm’s quarterly revenue was up 7.4% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.36 EPS. Research analysts forecast that Sabra Healthcare REIT, Inc. will post 1.45 EPS for the current fiscal year.

Sabra Healthcare REIT Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, August 29th. Investors of record on Friday, August 15th will be issued a dividend of $0.30 per share. The ex-dividend date of this dividend is Friday, August 15th. This represents a $1.20 dividend on an annualized basis and a yield of 6.5%. Sabra Healthcare REIT’s dividend payout ratio is 157.89%.

Insider Transactions at Sabra Healthcare REIT

In related news, Director Michael J. Foster sold 11,000 shares of the stock in a transaction dated Tuesday, May 20th. The stock was sold at an average price of $18.22, for a total transaction of $200,420.00. Following the sale, the director owned 64,725 shares of the company’s stock, valued at approximately $1,179,289.50. This represents a 14.53% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Company insiders own 1.20% of the company’s stock.

About Sabra Healthcare REIT

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.